TTN and cardiomyopathy: Furthermore, a recent study has identified telethonin as a target of the proteasome in a titin missense variant mouse model of cardiomyopathy, where degradation of unbound, cytoplasmic telethonin by the proteasome results in proteasomal overload (Jiang et al., 2021).